Skip to main content

Health Economics & Outcomes Research (HEOR) Module

Parthenon's HEOR module provides a comprehensive health economics engine for cost-effectiveness analysis, budget impact modeling, value-based contracting, and care gap identification. Built on top of the OMOP CDM, it connects real-world clinical evidence directly to economic evaluation, enabling payer-provider negotiations, formulary decisions, and health technology assessments grounded in your own patient data.

Module Architecture

OMOP CDM Data  -->  Cohort Definitions  -->  HEOR Analysis  -->  Scenarios  -->  Economic Results
| | |
Target Cohort Cost Parameters ICER / NMB / ROI
Comparator Cohort Utility Values Tornado Diagrams
Resource Use Budget Impact
|
Value-Based Contracts
Rebate Simulation

Analysis Types

The HEOR module supports five analysis types covering the major health economics evaluation frameworks:

TypeCodeDescriptionKey Output
Cost-Effectiveness AnalysisceaCompares costs and health outcomes of interventionsIncremental Cost-Effectiveness Ratio (ICER)
Cost-Benefit AnalysiscbaMonetizes health outcomes for direct comparisonNet Monetary Benefit (NMB)
Cost-Utility AnalysiscuaUses quality-adjusted life years (QALYs) as the outcome measureCost per QALY gained
Budget Impact Analysisbudget_impactProjects financial impact of adopting a new therapyYear 1, 3, and 5 budget impact
Return on InvestmentroiEvaluates investment return for health programsROI percentage, payback period

Creating an Analysis

Step 1: Define the Analysis

  1. Navigate to HEOR from the main navigation.
  2. Click New Analysis.
  3. Configure the analysis parameters:
FieldRequiredDescription
NameYesDescriptive analysis name
Analysis TypeYesCEA, CBA, CUA, Budget Impact, or ROI
DescriptionNoDetailed description of the analysis question
PerspectiveNoEconomic perspective: payer, societal, provider, or patient
Time HorizonNoEvaluation period: 1 year, 5 years, 10 years, or lifetime
Discount RateNoAnnual discount rate for future costs/outcomes (default: 3%, range: 0-20%)
CurrencyNoCurrency code (default: USD)
Data SourceNoOMOP source for real-world cost data
Target CohortNoParthenon cohort definition for the intervention group
Comparator CohortNoParthenon cohort definition for the comparator group
OMOP CDM integration

When a data source and cohorts are linked, the HEOR engine can pull real-world cost data from the OMOP cost table and clinical outcomes from the CDM tables, grounding your economic model in actual patient data rather than literature estimates alone.

Step 2: Define Scenarios

Each analysis contains one or more scenarios representing different modeling assumptions:

FieldDescription
NameScenario label (e.g., "Base Case", "Optimistic", "Conservative")
Scenario Typeintervention -- the new therapy; comparator -- current standard of care; sensitivity -- parameter variation
DescriptionExplanation of scenario assumptions
Parameter OverridesJSON object overriding base-case parameter values
Is Base CaseBoolean flag (only one scenario can be the base case)
Sort OrderDisplay ordering
Base case convention

Always create at least two scenarios: an intervention base case and a comparator base case. Sensitivity scenarios vary individual parameters around the base case to test robustness.

Step 3: Define Cost Parameters

Add cost and utility parameters to your analysis:

FieldRequiredDescription
Parameter NameYesDescriptive name (e.g., "Osimertinib annual cost")
Parameter TypeYesCategory (see table below)
ValueYesNumeric value
UnitNoUnit of measurement (USD, QALY, per patient, etc.)
Lower BoundNoLow end for sensitivity analysis
Upper BoundNoHigh end for sensitivity analysis
DistributionNoStatistical distribution: normal, gamma, beta, log_normal, uniform
OMOP Concept IDNoLink to OMOP concept for data-driven parameters
Source ReferenceNoLiterature citation or data source

Parameter Types

TypeCodeDescriptionExamples
Drug Costdrug_costAcquisition cost of medicationsAnnual drug cost, per-dose cost
Administration Costadmin_costCost of administering the therapyInfusion center, nurse time
HospitalizationhospitalizationInpatient stay costsICU day, general ward day
ER Visiter_visitEmergency department costsPer-visit ER cost
QALY Weightqaly_weightQuality-adjusted life year weightsHealth state utility
Utility Valueutility_valueHealth state utility values (0-1)Progression-free, post-progression
Resource Useresource_useHealthcare resource utilizationPhysician visits/year, lab tests/year
Avoided Costavoided_costCosts prevented by the interventionAvoided hospitalizations
Program Costprogram_costImplementation and program costsScreening program cost, training

Step 4: Run the Analysis

  1. Ensure at least one scenario is defined.
  2. Click Run Analysis on the analysis detail page.
  3. The HeorEconomicsService computes results for each scenario.
  4. Status transitions: draft -> running -> completed (or failed).

Understanding Results

Result Fields

Each scenario produces a result record with:

FieldDescription
Total CostAggregate cost for this scenario
Total QALYsQuality-adjusted life years gained
Total Life YearsUnadjusted life years
Incremental CostCost difference vs. comparator
Incremental QALYsQALY difference vs. comparator
ICERIncremental cost-effectiveness ratio (cost per QALY gained)
Net Monetary BenefitNMB at the willingness-to-pay threshold
Willingness-to-Pay ThresholdWTP used for NMB calculation
ROI PercentReturn on investment percentage (for ROI analyses)
Payback PeriodMonths until investment is recovered (for ROI analyses)
Budget Impact (Year 1/3/5)Projected budget impact (for budget impact analyses)
Cohort SizeNumber of patients in the analysis

Tornado Diagram

For sensitivity analyses, results include tornado data showing how each parameter affects the ICER:

FieldDescription
ParameterName of the varied parameter
Base ValueParameter's base-case value
Low/High ValueTested lower and upper bound
Low/High ICERResulting ICER at each bound
RangeICER range (measures parameter sensitivity)

The tornado diagram ranks parameters by their impact on the ICER, helping identify which inputs most affect the economic conclusion. Parameters at the top of the tornado have the greatest influence and warrant the most scrutiny in data sourcing.

Interpreting ICER
  • ICER below WTP threshold -- the intervention is cost-effective
  • ICER above WTP threshold -- the intervention is not cost-effective at this price
  • Negative ICER (cost-saving) -- the intervention saves money while improving outcomes (dominant strategy)
  • Common WTP thresholds: $50,000/QALY (conservative), $100,000/QALY (moderate), $150,000/QALY (generous)

Value-Based Contracts

The HEOR module includes a value-based contracting system for outcomes-linked pricing agreements between payers and manufacturers:

Contract Types

TypeCodeDescription
Outcomes-Basedoutcomes_basedRebates tied to real-world outcome achievement
AmortizedamortizedPayment spread over time, linked to continued benefit
WarrantywarrantyManufacturer guarantees outcomes; refund if not achieved

Creating a Contract

  1. Navigate to HEOR > Contracts.
  2. Click New Contract.
  3. Configure:
FieldRequiredDescription
Contract NameYesDescriptive contract name
AnalysisYesLink to an HEOR analysis
Drug NameNoDrug under contract
Contract TypeNooutcomes_based, amortized, or warranty
Outcome MetricYesClinical endpoint being measured (e.g., "30-day readmission rate")
Baseline RateNoExpected outcome rate without intervention
List PriceNoDrug list price per unit
Net Price FloorNoMinimum net price after rebates
Measurement PeriodNoMonths over which outcomes are measured
Effective DateNoContract start date
Rebate TiersNoTiered rebate structure (see below)

Rebate Tiers

Rebate tiers define outcome-linked pricing adjustments:

[
{ "threshold": 0.05, "rebate_percent": 10 },
{ "threshold": 0.10, "rebate_percent": 20 },
{ "threshold": 0.20, "rebate_percent": 35 }
]

Each tier specifies: if the outcome improvement exceeds the threshold, the corresponding rebate percentage applies. Tiers are evaluated in order; the highest qualifying tier is used.

Rebate Simulation

Simulate contract rebates based on observed real-world outcomes:

  1. Open a contract detail page.
  2. Enter the observed outcome rate from your real-world data.
  3. Click Simulate Rebate.
  4. The system computes:
    • Which rebate tier applies
    • Rebate percentage and dollar amount
    • Net price after rebate
    • Comparison to baseline rate

This enables payers to model financial scenarios before finalizing contract terms.

HEOR Dashboard

The main HEOR page displays:

Statistics Bar

MetricDescription
Total AnalysesNumber of analyses created by the current user
CompletedAnalyses with computed results
Total ContractsValue-based contracts managed
By TypeBreakdown of analyses by type (CEA, CBA, CUA, etc.)

Analysis List

Sortable table of all analyses with:

  • Name, type, status, perspective, time horizon
  • Created and last updated timestamps
  • Quick actions (view, edit, run, delete)

Contract List

Separate tab showing all value-based contracts with status (draft, active, expired).

API Reference

Key HEOR API endpoints:

EndpointMethodDescription
/api/v1/heor/statsGETModule statistics
/api/v1/heor/analysesGET, POSTList/create analyses
/api/v1/heor/analyses/{id}GET, PUT, DELETECRUD for analysis
/api/v1/heor/analyses/{id}/scenariosGET, POSTList/create scenarios
/api/v1/heor/analyses/{id}/scenarios/{sid}PUT, DELETEUpdate/delete scenario
/api/v1/heor/analyses/{id}/parametersGET, POSTList/create parameters
/api/v1/heor/analyses/{id}/parameters/{pid}PUT, DELETEUpdate/delete parameter
/api/v1/heor/analyses/{id}/runPOSTExecute analysis
/api/v1/heor/analyses/{id}/resultsGETRetrieve results
/api/v1/heor/contractsGET, POSTList/create contracts
/api/v1/heor/contracts/{id}GET, PUT, DELETECRUD for contract
/api/v1/heor/contracts/{id}/simulate-rebatePOSTSimulate rebate
Regulatory compliance

HEOR analyses produced by Parthenon are research tools. Economic models used for regulatory submissions (e.g., HTA dossiers, AMCP Format submissions) require additional validation, sensitivity analyses, and expert review beyond what the platform automates. Consult health economics methodologists for regulatory-grade deliverables.